MB12

· Laboratorio Elea Phoenix S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MB12, covering 2024-07-16 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study) [Phase 3]

See pricing